|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-9-5
|
|
pubmed:abstractText |
Adherence is now one of the major issues in the management of osteoporosis and several papers have suggested that vertebral fractures might be increased in patients who do not follow appropriately their prescriptions. This paper relates the strong relationship existing between adherence to anti-osteoporosis treatment and the risk of subsequent hip fracture.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0937-941X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
811-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17999022-Aged,
pubmed-meshheading:17999022-Alendronate,
pubmed-meshheading:17999022-Bone Density Conservation Agents,
pubmed-meshheading:17999022-Diphosphonates,
pubmed-meshheading:17999022-Drug Administration Schedule,
pubmed-meshheading:17999022-Epidemiologic Methods,
pubmed-meshheading:17999022-Female,
pubmed-meshheading:17999022-Hip Fractures,
pubmed-meshheading:17999022-Humans,
pubmed-meshheading:17999022-Middle Aged,
pubmed-meshheading:17999022-Osteoporosis, Postmenopausal,
pubmed-meshheading:17999022-Patient Compliance,
pubmed-meshheading:17999022-Raloxifene
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women.
|
|
pubmed:affiliation |
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, University of Liège, Liège, Belgium. veronique.rabenda@ulg.ac.be
|
|
pubmed:publicationType |
Journal Article
|
